Papers matching “vulnerability disclosure” 18
Not finding it? Sign in to also search OpenAlex live.
-
Eradicating the Unseen: Detecting, Exploiting, and Remediating a Path Traversal Vulnerability across GitHub2025 ACM Asia Conference on Computer and Communications Security (ASIA CCS) conference-paper Computer Science Web Application Security Vulnerabilities Open access
Jafar Akhoundali, Hamidreza Hamidi, Kristian F. D. Rietveld, Olga Gadyatskaya
8citations -
Eradicating the Unseen: Detecting, Exploiting, and Remediating a Path Traversal Vulnerability across GitHub2025 arXiv (Cornell University) preprint Computer Science Web Application Security Vulnerabilities Open access
Jafar Akhoundali, Hamidreza Hamidi, Kristian F. D. Rietveld, Olga Gadyatskaya
0citations -
Executive Changes and ESG Disclosure in S&P 500 Firms: The Moderating Role of Strategic Dynamism2026 Business Strategy and the Environment article Business, Management and Accounting Corporate Social Responsibility Reporting Open access
Christian Schöndeling, Carolin Krieweth, Sebastian Kruse, Malte Brettel
0citations -
Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
Anne Mea Spanjaart, Per T Ljungman, Rafael de la Cámara, Gloria Tridello, Valentín Ortiz‐Maldonado, Álvaro Urbano-Ispizúa, +28 more
16citations -
Explorations on the use of lived experiences by psychiatrists: facilitators and barriers2022 Mental Health and Social Inclusion article Health Professions Mental Health and Patient Involvement Open access
Simona Karbouniaris, Marjolein Boomsma-van Holten, Antoinet Oostindiër, Pascal Raats, Cecil C. Prins-Aardema, Alie Weerman, +2 more
5citations -
POS0253 DIFFERENCES IN THE EFFECT OF C4A and C4B COPY NUMBERS ON SSc SEROLOGICAL AND CLINICAL SUBTYPES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Sclerosis and Related Diseases Open access
Joaquín Martínez‐López, Carlos Rangel‐Peláez, Inmaculada Rodriguez‐Martin, Alfredo Guillén del Castillo, Carmen Pilar Simeón‐Aznar, José Luís Callejas-Rubio, +14 more
0citations -
POS0409 HEALTHCARE STRUCTURES FOR RARE (METABOLIC) DISEASES IN GERMANY – HEALTHCARE RESEARCH USING STATUTORY HEALTH INSURANCE (SHI) DATA [SCOPE-RD: STUDY OF COVID-19 OUTCOMES IN PATIENTS WITH RARE DISEASES]2025 Annals of the Rheumatic Diseases conference-abstract Medicine COVID-19 and healthcare impacts Open access
Lukas Völkel, Lucas R.D. Fahrenschon, Martin Mücke, Benno Neukirch, Annette Doris Wagner
0citations -
485. Improved Outcome of COVID-19 in CAR T Cell Treated Patients; results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group2023 Open Forum Infectious Diseases article Medicine COVID-19 Clinical Research Studies Open access cited by 1 patent
Per T Ljungman, Anne Mea Spanjaart, Gloria Tridello, Nina Simone Knelange, Rafael de la Cámara, Marie José Kersten, +1 more
0citations
18 results